Advertisement
Advertisement

GLMD

GLMD logo

Galmed Pharmaceuticals Ltd.

0.59
USD
Sponsored
-0.01
-1.46%
Aug 10, 14:58 UTC -4
Closed
exchange

After-Market

0.59

0.00
-0.02%

Galmed Pharmaceuticals Ltd. Profile

About

Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company. It is focused on developing therapies for liver diseases and gallstones. Galmed Pharmaceuticals Ltd. is based in Tel Aviv, Israel.

Info & Links

CEO

Allen Baharaff

Headquarters

16 ABBA HILLEL ROAD
RAMAT GAN, L3 5250608, ISRAEL

Industry

Medical Drugs

Sector

Medical

Website

www.galmedpharma.com

Auditor

Brightman Almagor Zohar & Co.

Share holders

8

Employees

9

Galmed Pharmaceuticals Ltd. Statistics

Valuation Measures

Market Capitalization2

4.90M

Enterprise Value

3.17M

Enterprise Value/EBITDA(ttm)

-0.34

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.28

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-35.32%

Return on Invested Capital(ttm)

-66.28%

Return on Assets(ttm)

-30.94%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

--

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-9.30M

Net Income Available to Common(ttm)

-11.11M

Diluted EPS(ttm)

-0.91

Share Statistics

Beta (5Y Monthly)

0.74

52-Week Change

-59.10%

S&P 500 52-Week Change

21.65%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

5.29M

% Held by Insiders

19.80%

% Held by Institutions

76.14%

Balance Sheet

Total Cash(mrq)

7.80M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

7.71%

Quick Ratio(mrq)

7.71%

Book Value Per Share(mrq)

2.11

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.38

Free Cash Flow(ytd)

-2.54M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement